Skip to main content
. 2019 Nov 6;26(5):1578–1588. doi: 10.1038/s41380-019-0578-y

Table 2.

Median (IQR) of 25OHD concentrations in nmol/L

Maternal 25OHD (natural) Maternal 25OHD (standardized to 10.9 weeks gestation) Neonatal 25OHD
Entire sample 54.2 (33.9, 73.1) 57.1 (45.8, 65.1) 26.1 (17.4, 38.2)
Nordic-born mothers 59.5 (45.0, 77.4) 60.0 (53.0, 68.2) 29.3 (20.8, 41.2)
Non-Nordic born mothers 26.7 (15.6, 44.2) 30.8 (22.7, 45.1) 15.1 (9.8, 23.0)
By outcome status (entire sample)
 ASD 50.2 (32.6, 68.4) 55.1 (45.7, 64.0) 25.7 (17.5, 37.6)
 ASD with ID 43.8 (19.7, 63.8) 49.7 (28.7, 63.2) 22.7 (14.3, 34.1)
 ASD without ID 54.2 (36.5, 69.7) 57.2 (49.0, 64.2) 26.9 (18.8, 39.2)
 No ASD 56.1 (35.1, 76.3) 58.1 (46.3, 66.5) 26.6 (17.3, 38.6)
By outcome status (Nordic-born mothers)
 ASD 56.4 (42.5, 73.7) 58.9 (51.7, 66.9) 28.9 (20.6, 40.7)
 ASD with ID 57.7 (43.8, 73.8) 59.8 (51.7, 68.5) 29.3 (20.7, 41.0)
 ASD without ID 56.1 (42.4, 73.3) 58.8 (51.8, 65.7) 28.7 (20.6, 40.5)
 No ASD 62.3 (47.6, 79.6) 60.8 (54.3, 68.7) 29.7 (21.0, 42.2)

Number of maternal samples = 1023; Number of neonatal samples = 3006